Nurse-led COPD Self-management Intervention
The Effect of Rational Drug Use and Symptom Control Training on Self-efficacy, Emotional Status and Clinical Parameters in COPD (Chronic Obstructive Pulmonary Disease)
1 other identifier
interventional
41
1 country
1
Brief Summary
Introduction: Chronic Obstructive Pulmonary Disease (COPD) disease highest mortality and morbidity of respiratory diseases that third cause of death in the world and Turkey. Purpose: Purpose of study improve self-efficacy, anxiety/depression, symptom control and exercise capacity, reduce use of health care of COPD patients. Method: The study was conducted with a randomized controlled design. This study were included 41 COPD patients (İntervention=20, Control=21). Data collection tools were patient description form, COPD Self-Efficacy Scale (CSES), COPD Assessment Test (CAT), Hospital Anxiety Depression Scale (HAD), 6-Minute Walk Test (MWT) and tele-health form. Intervention consists patient education, training booklet and 3 month follow-up. Control group patients received only general care. The final test was performed three months later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2019
CompletedFirst Submitted
Initial submission to the registry
June 24, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedFebruary 14, 2022
January 1, 2022
6 months
June 24, 2020
January 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
COPD Self-Efficacy Score
Scales were filled in by interviewing each participant.Scoring is done between 1-5 points. Increased score indicates an increase in self-efficacy in coping with respiratory distress.
Change from baseline COPD self-efficacy score at 3 months
COPD Assessment Test Score
Scales were filled in by interviewing each participant.Scoring is done between 0-40 points. Increased points indicate that the severity of the disease decreases.
Change from baseline COPD assessment test score at 3 months
Anxiety Depression Score
Scales were filled in by interviewing each participant. Turkey cut-off score of the scale used for anxiety, 10, were found to be 7 for depression. Participants who scored above these points were evaluated as risky.
Change from baseline anxiety depression test score at 3 months
6-Minute Walk Test
Each participant received a 6-minute walk test as recommended by the AmericanThoracic Society.
Change from baseline 6-minute walk distance at 3 months
Secondary Outcomes (1)
Number of health care uses
Change in the number of initial health care use in the 3rd month
Study Arms (2)
Study group
EXPERIMENTALStudy group intervention consists patient education, training booklet and 3 month follow-up.
Control group
NO INTERVENTIONControl group received only general care
Interventions
Patient education includes general disease information, COPD self-management and symptom control. The education face-to-face and practical training was provided by the researcher. The training booklet was prepared by the researcher. The readability of the booklet was very easy and its comprehensibility was tested by pre-application. Tele monitoring was done by the researcher for support and motivation. The participants were called 4 times by phone.
Eligibility Criteria
You may qualify if:
- Having a diagnosis of COPD
- Being inpatient at chest diseases clinic
- Being literate
- Able to use a telephone
- No communication disabilities
- Being volunteers
You may not qualify if:
- Having mental illness
- Respiratory comorbidity (lung cancer, interstitial lung disease, pulmonary tuberculosis),
- Unable to attend the post-tests
- Not reachable by phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Denizli Public Hospitals Association, Buldan Chest Diseases Hospital
Denizli, 20000, Turkey (Türkiye)
Related Publications (4)
Kasikci MK. Using self-efficacy theory to educate a patient with chronic obstructive pulmonary disease: A case study of 1-year follow-up. Int J Nurs Pract. 2011 Feb;17(1):1-8. doi: 10.1111/j.1440-172X.2010.01898.x.
PMID: 21251148BACKGROUNDGlobal Initiative for Chronic Obstructive Lung Disease, From the Global Strategy for the Diagnosis, Management and Prevention of COPD, GOLD 2017, p.139. https://goldcopd.org/wp-content/uploads/2017/02/wms-GOLD-2017-FINAL.pdf (access date: 10.08.2018)
BACKGROUNDHarrison SL, Janaudis-Ferreira T, Brooks D, Desveaux L, Goldstein RS. Self-management following an acute exacerbation of COPD: a systematic review. Chest. 2015 Mar;147(3):646-661. doi: 10.1378/chest.14-1658.
PMID: 25340578BACKGROUNDTrappenburg JC, Koevoets L, de Weert-van Oene GH, Monninkhof EM, Bourbeau J, Troosters T, Verheij TJ, Lammers JW, Schrijvers AJ. Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med. 2009 Dec 29;9:52. doi: 10.1186/1471-2466-9-52.
PMID: 20040088RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nevin K Kurban, Prof. Dr.
Consultant, Responsible researcher
- PRINCIPAL INVESTIGATOR
Şenay Takmak, pHd
pHd student, Assistant researcher
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
June 24, 2020
First Posted
July 7, 2020
Study Start
August 28, 2018
Primary Completion
February 17, 2019
Study Completion
May 30, 2019
Last Updated
February 14, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Findings can be shared after the study has been published.
- Access Criteria
- The sociodemographic and disease-related characteristics of the participants, the pre-post-test findings including the answers to the research questions and statistical analyzes will be shared.
Study results will be announced in a publication.